Systemic reduction of functionally suppressive CD4dimCD25 highFoxp3+ tregs in human second trimester pregnancy is induced by progesterone and 17β-estradiol

Journal of Immunology

Volumn 183, Issue 1, 2009, Pages 759-769

  Mjösberg, Jenny ^a   Svensson, Judit ^a   Johansson, Emma ^a   Hellström, Lotta ^a   Casas, Rosaura ^a   Jenmalm, Maria C ^a   Boij, Roland ^b   Matthiesen, Leif ^c   Jönsson, Jan Ingvar ^a   Berg, Göran ^a   Ernerudh, Jan ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c HELSINGBORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ESTRADIOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; PROGESTERONE; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; PLACENTA PROTEIN;

ADULT; ARTICLE; COCULTURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FREQUENCY ANALYSIS; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SECOND TRIMESTER PREGNANCY; T LYMPHOCYTE SUBPOPULATION; BIOSYNTHESIS; BLOOD; CD4 CD8 RATIO; CELL CULTURE; COMPARATIVE STUDY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE DEPLETION; METABOLISM; METHODOLOGY; PHYSIOLOGY; PREGNANCY;

ADULT; ANTIGENS, CD4; CD4-CD8 RATIO; CELLS, CULTURED; ESTRADIOL; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; PROGESTERONE; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 68949083419     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803654     Document Type: Article

References (51)

1. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
2. high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253.
3. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
4. + regulatory T cells. Nat. Immunol. 4: 330-336.
5. + T cells. Eur. J. Immunol. 37: 129-138.
6. - T cells. J. Clin. Invest. 112: 1437-1443.
7. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19: 345-354.
8. + regulatory T cells are new therapeutic targets. Front. Biosci. 13: 1472-1499.
9. Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203: 1693-1700.
10. + T reg cells. J. Exp. Med. 203: 1701-1711.
11. Baecher-Allan, C., E. Wolf, and D. A. Hafler. 2006. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176: 4622-4631.
12. Sansom, D. M., and L. S. Walker. 2006. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol. Rev. 212: 131-148.
13. Aluvihare, V. R., M. Kallikourdis, and A. G. Betz. 2004. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5: 266-271.
14. + T regulatory cells prevents fetal rejection in a murine abortion model. Am. J. Pathol. 166: 811-822.
15. Zenclussen, A. C., K. Gerlof, M. L. Zenclussen, S. Ritschel, A. Zambon Bertoja, S. Fest, S. Hontsu, S. Ueha, K. Matsushima, et al. 2005. Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface. Eur. J. Immunol. 36: 82-94.
16. Polanczyk, M. J., C. Hopke, A. A. Vandenbark, and H. Offner. 2006. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res. 84: 370-378.
17. + regulatory T cell pool during pregnancy. J. Reprod. Immunol. 75: 71-81.
18. + regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs. Immunology 120: 456-466.
19. + regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod. 10: 347-353.
20. - T-cells in decidua and maternal blood during human pregnancy. Placenta 27(Suppl. A): S47-S53.
21. Heikkinen, J., M. Mottonen, A. Alanen, and O. Lassila. 2004. Phenotypic characterization of regulatory T cells in the human decidua. Clin. Exp. Immunol. 136: 373-378.
22. + regulatory T-cell subset. Immunology 112: 38-43.
23. bright regulatory T cells in pre-eclampsia. Clin. Exp. Immunol. 149: 139-145.
24. Prieto, G. A., and Y. Rosenstein. 2006. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology 118: 58-65.
25. Sacks, G., I. Sargent, and C. Redman. 1999. An innate view of human pregnancy. Immunol. Today 20: 114-118.
26. Ekerfelt, C., L. Matthiesen, G. Berg, and J. Ernerudh. 1997. Paternal leukocytes selectively increase secretion of IL-4 in peripheral blood during normal pregnancies: demonstrated by a novel one-way MLC measuring cytokine secretion. Am. J. Reprod. Immunol. 38: 320-326. (Pubitemid 27427394)
27. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193: 1285-1294.
28. high regulatory T cells. Blood 104: 895-903.
29. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6: R335-R346.
30. + regulatory T cells in inflamed synovia. J. Exp. Med. 201: 1793-1803.
31. Stites, D. P., and P. K. Siiteri. 1983. Steroids as immunosuppressants in pregnancy. Immunol. Rev. 75: 117-138.
32. Arck, P., P. J. Hansen, B. Mulac Jericevic, M. P. Piccinni, and J. Szekeres-Bartho. 2007. Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am. J. Reprod. Immunol. 58: 268-279.
33. Soldin, O. P., T. Guo, E. Weiderpass, R. E. Tractenberg, L. Hilakivi-Clarke, and S. J. Soldin. 2005. Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry. Fertil. Steril. 84: 701-710.
34. O'Leary, P., P. Boyne, P. Flett, J. Beilby, and I. James. 1991. Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin. Chem. 37: 667-672.
35. Lang, T. J. 2004. Estrogen as an immunomodulator. Clin. Immunol. 113: 224-230.
36. Szekeres-Bartho, J., A. Barakonyi, G. Par, B. Polgar, T. Palkovics, and L. Szereday. 2001. Progesterone as an immunomodulatory molecule. Int. Immunopharmacol. 1: 1037-1048.
37. + regulatory T cell compartment. J. Immunol. 173: 2227-2230.
38. Polanczyk, M. J., C. Hopke, J. Huan, A. A. Vandenbark, and H. Offner. 2005. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J. Neuroimmunol. 170: 85-92.
39. Hirano, S., D. Furutama, and T. Hanafusa. 2007. Physiologically high concentrations of 17β-estradiol enhance NF-κB activity in human T cells. Am. J. Physiol. 292: R1465-R1471.
40. Bettelli, E., M. Dastrange, and M. Oukka. 2005. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102: 5138-5143.
41. + regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol. 178: 2572-2578.
42. Whitacre, C. C., S. C. Reingold, and P. A. O'Looney. 1999. A gender gap in autoimmunity. Science 283: 1277-1278.
43. Druckmann, R., and M. A. Druckmann. 2005. Progesterone and the immunology of pregnancy. J. Steroid Biochem. Mol. Biol. 97: 389-396.
44. Straub, R. H. 2007. The complex role of estrogens in inflammation. Endocr. Rev. 28: 521-574.
45. bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J. Immunol. 180: 5737-5745.
46. Wegmann, T. G., H. Lin, L. Guilbert, and T. R. Mosmann. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14: 353-356.
47. Achidi, E. A., T. O. Apinjoh, and V. P. Titanji. 2007. Malaria parasitemia and systemic cytokine bias in pregnancy. Int. J Gynaecol. Obstet. 97: 15-20.
48. Matthiesen, L., M. Khademi, C. Ekerfelt, G. Berg, S. Sharma, T. Olsson, and J. Ernerudh. 2003. In-situ detection of both inflammatory and anti-inflammatory cytokines in resting peripheral blood mononuclear cells during pregnancy. J. Reprod. Immunol. 58: 49-59.
49. Saito, S., M. Sakai, Y. Sasaki, K. Tanebe, H. Tsuda, and T. Michimata. 1999. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin. Exp. Immunol. 117: 550-555.
50. Gavin, M. A., J. P. Rasmussen, J. D. Fontenot, V. Vasta, V. C. Manganiello, J. A. Beavo, and A. Y. Rudensky. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775.
51. Wan, Y. Y., and R. A. Flavell. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770.